A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG-banding and fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 89, Issue 2, 1996, Pages 157-162

  Young, Carolyn ^a   Di Benedetto Jr , Joseph ^a   Glasser, Lewis ^a   Mark, Hon Fong Louie ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC ACCURACY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC LINKAGE; HUMAN; LEUKEMOGENESIS; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030586180     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(96)00029-5     Document Type: Article

References (19)

1. 1. Rowley JD (1973): A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 234:290-293.
2. 2. Mark HFL (1994): Bone marrow cytogenetics and hematologic malignancies. In: The Cytogenetic Symposia 1994. BJ Kaplan, KS Dale, eds. The Association of Cytogenetic Technologists, Burbank, CA, pp. 8-1-8-6.
3. 3. LeBeau MM (1991): Cytogenetic analysis of hematological malignant diseases, In: Barch MJ (Ed.) The ACT Cytogenetics Laboratory Manual, 2nd Ed., MJ Barch, ed. Raven Press, New York.
4. 4. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer, 5th Ed. Wiley-Liss, New York, pp. 2162-2164.
5. 5. Tomiyasu T, Sasaki M, Kondo K, Okada M (1982); Chromosomal banding studies in 106 cases of chronic myelogenous leukemia. Jpn J Human Genetics 27:243-258.
6. 6. Moorhead P, Nowell P, Mailman W (1960): Chromosome preparation of leukocytes cultured from human peripheral blood. Exp Cell Res 20:613-616.
7. 7. Sunnier AT, Evan AJ, Buckland RA (1971): New technique for distinguishing between human chromosomes. Nature 232:31-32.
8. 8. Mark HFL, Ahearn J, Lathrop JC (1995): Constitutional trisomy 8 mosaicism and gestational trophoblastic disease. Cancer Genetics Cytogenetics 80:150-154.
9. 9. Braun L, Mikimo R, Mark HFL, Lauchlan S (1993): Establishment of biologically heterogeneous cell lines from primary cervical tumors of different histological grade. Am J Pathology 143:832-844.
10. 10. Mark HFL, Hann E, Mikumo R, Lauchlan S, Beauregard L, Braun L (1995): Cytogenetic characterization of three cell lines derived from primary cervical tumors. Annals of Clin and Lab Science 25:193-207.
11. 11. Pinkel D, Strawne R, Gray J (1986): Cytogenetic analysts using quantitative high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 83:2934-2938.
12. 12. Mark HFL, Santoro K, Jackson C (1992): Characterization of chromosome 9 and 19 somatic cell and radiation hybrids: A comparison of approaches. Appl Cytogenet 18:149-156.
13. 13. Mark HFL (1994): Fluorescent in situ hybridization as an adjunct to conventional cytogenetics. Ann of Clinic and Lab Sci 24(2):153-163.
14. 14. Hernandez J (1994): White cells, lymph node and spleen, In: Robbins Pathologic Basis of Disease, 5 ed., Cotran RS, Kumar V, Robbins SL, eds. W.B. Saunders Company, Philadelphia, PA, pp.272, 654-655.
15. 15. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M (1993): Chronic myelogenous leukemia: A concise update, Blood 82(3):691-703.
16. 16. Gordon MY, Dowding CR, Riley GP, et al. (1987): Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myelogenous leukemia. Nature 328:342.
17. 17. Schlossman F, Chess L, Humphreys RE, Strominger JL (1976): Distribution of la-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci USA 73:1288.
18. 18. Upadhyaya G, Deisseroth A, Emerson S (1988): CML progenitor cells are deficient in cell surface LFA-3; modulation by alpha-interferon in vitro and in vivo. Blood 72:231a (abstr 836, suppl 1).
19. 19. Baccarani M (1992) for the Italian Cooperative Study Group on Chronic Myelogenous Leukemia: Prognostic study of alpha-interferon (IFN)-treated chronic myelogenous leukemia (CML) patients: II. Predicting survival. Chronic Myelogenous Leukemia, 2nd International Conference. Bologna, Italy, p. 163.